H.R. 4866 · 116th Congress

National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2020

Stage
Passed a chamber
Sponsor
Frank Pallone
Introduced
2019-10-28
Latest action
2020-09-22 · Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Action history

  1. 2020-09-22Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  2. 2020-09-21Motion to reconsider laid on the table Agreed to without objection.
  3. 2020-09-21On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
  4. 2020-09-21DEBATE - The House proceeded with forty minutes of debate on H.R. 4866.
  5. 2020-09-21Considered under suspension of the rules.
  6. 2020-09-21Mrs. Dingell moved to suspend the rules and pass the bill, as amended.
  7. 2020-09-17Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-513.
  8. 2020-09-17Placed on the Union Calendar, Calendar No. 413.
  9. 2020-07-15Committee Consideration and Mark-up Session Held.
  10. 2020-07-15Ordered to be Reported (Amended) by Voice Vote.
  11. 2020-03-11Subcommittee Consideration and Mark-up Session Held.
  12. 2020-03-11Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
  13. 2019-10-29Referred to the Subcommittee on Health.
  14. 2019-10-28Introduced in House
  15. 2019-10-28Referred to the House Committee on Energy and Commerce.